Copper-induced oxidative damage on astrocytes: Protective effect exerted by human high density lipoproteins

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1635, Issue 1, 2003, Pages 48-54

  Ferretti, Gianna ^a   Bacchetti, Tiziana ^a   Moroni, Cinzia ^a   Vignini, Arianna ^a   Curatola, Giovanna ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

2 ,7 dichloro dihydrofluorescein diacetate (H2DCFDA); Astrocyte; Copper; High density lipoprotein; Lipid peroxidation; Neurodegenerative disease

Indexed keywords

COPPER ION; DICHLORODIHYDROFLUORESCEIN DIACETATE; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; HIGH DENSITY LIPOPROTEIN; HYDROPEROXIDE; LIPID HYDROPEROXIDE; LIPOPROTEIN; METAL ION; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CELL COMPOSITION; CELL LABELING; CELL LEVEL; CELL MEMBRANE TRANSPORT; CELL TYPE; CELL VIABILITY; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFECT; DRUG MECHANISM; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIPID COMPOSITION; LIPID PEROXIDATION; METAL BINDING; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NORMAL HUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 0345258060     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2003.10.005     Document Type: Article

References (37)

1. Perry G., Sayre L.M., Atwood C.S., Castellani R.J., Cash A.D., Rottkamp C.A., Smith M.A. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs. 16(5):2002;339-352.
2. Rotilio G., Carri M.T., Rossi L., Circolo M.R. Copper-dependent oxidative stress and neurodegeneration. IUBMB Life. 50(4-5):2000;309-314.
3. Simonian N.A., Coyle J.T. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36:1996;83-106.
4. Marcus D.L., Thomas C., Rodriguez C., Simberkoff K., Tsai J.S., Strafaci J.A., Freedman M.L. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp. Neurol. 150(1):1998;40-44.
5. Dei R., Takeda A., Niwa H., Li M., Nakagomi Y., Watanabe M., Inagaki T., Washimi Y., Yasuda Y., Horie K., Miyata T., Sobue G. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease. Acta Neuropathol. (Berl.). 104(2):2002;113-122.
6. Desagher S., Glowinski J., Premont J. Astrocytes protect neurons from hydrogen peroxide toxicity. J. Neurosci. 16(8):1996;2553-2562.
7. Klamt F., Gottfried C., Tramontina F., Dal-Pizzol F., Da Frota M.L., Moreira J.C., Dias R.D., Moriguchi E., Wofchuk S., Souza D.O. Time-related increase in mitochondrial superoxide production, biomolecule damage and antioxidant enzyme activities in cortical astrocyte cultures. NeuroReport. 13(12):2002;1515-1518.
8. Servitja J.M., Masgrau R., Pardo R., Sarri E., Picatoste F. Effects of oxidative stress on phospholipid signalling in rat cultured astrocytes and brain slices. J. Neurochem. 75(2):2000;788-794.
9. Chen S.H., Liu S.H., Liang Y.C., Lin J.K., Lin-Shiau S.Y. Oxidative stress and c-Jun-amino-terminal kinase activation involved in apoptosis of primary astrocytes induced by disulfiram-Cu (2+) complex. Eur. J. Pharmacol. 414(2-3):2001;177-188.
10. Rohrdanz E., Schmuck G., Ohler S., Tran-Thi Q.H., Kahl R. Changes in antioxidant enzyme expression in response to hydrogen peroxide in rat astroglial cells. Arch. Toxicol. 75(3):2001;150-158.
11. Parthasarathy S., Barnett J., Fong L.G. High-density lipoprotein inhibits the oxidative modification of low-density lipoproteins. Biochim. Biophys. Acta. 1044(2):1990;275-283.
12. Mackness M.I., Durrington P.N., Mackness B. How high-density lipoprotein protects against the effects of lipid peroxidation. Curr. Opin. Lipidol. 11(4):2000;383-388.
13. 2+-induced oxidation of astrocytes. J. Trace Elem. Med. Biol. 17(3):2003;25-30.
14. Klimov A.N., Kozhevnikova K.A., Kuzmin A.A., Kuznetsov A.S., Belova E.V. On the ability of high density lipoproteins to remove phospholipid peroxidation products from erythrocyte membranes. Biochemistry (Mosc.). 66(3):2001;300-304.
15. Koch S., Donarski N., Goetze K., Kreckel M., Stuerenburg H.J., Buhmann C., Beisiegel U. Characterization of four lipoprotein classes in human cerebrospinal fluid. J. Lipid Res. 42(7):2001;1143-1151.
16. Ladu M.J., Reardon C., Van Eldik L., Fagan A.M., Bu G., Holtzman D., Getz G.S. Lipoproteins in the central nervous system. Ann. N.Y. Acad. Sci. 903:2000;167-175.
17. Pitas R.E., Boyles J.K., Lee S.H., Foss D., Mahley R.W. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein-E containing lipoproteins. Biochim. Biophys. Acta. 917(1):1987;148-161.
18. Bassett C.N., Montine K.S., Neely M.D., Swift L.L., Montine T.J. Cerebrospinal fluid lipoproteins in Alzheimer's disease. Microsc. Res. Tech. 50(4):2000;282-286.
19. Pall H.S., Williams A.C., Blake D.R., Lunec J., Gutteridge J.M., Hall M., Taylor A. Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet. 2(8553):1987;238-241.
20. Squitti R., Lupoi D., Pasqualetti P., Dal Forno G., Vernieri F., Chiovenda P., Rossi L., Cortesi M., Cassetta E., Rossigni P.M. Elevation of serum copper levels in Alzheimer's disease. Neurology. 59(8):2002;1153-1161.
21. Chung B.H., Segrest J.P., Ray M.J., Brunzell J.D., Hokanson J.E., Krauss R.M., Beaudrie K., Cone J.T. Single vertical spin density gradient ultracentrifugation. Methods Enzymol. 128:1986;181-209.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall P.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
23. Freshney R.I. Culture of Animal Cells: A Manual of Basic Technique. 2000;Wiley, New York.
24. Oyama Y., Hayashi A., Ueha T., Maekawa K. Characterization of 2′,7′-dichlorofluorescin fluorescence in dissociated mammalian brain neurons: estimation on intracellular content of hydrogen peroxide. Brain Res. 635(1-2):1994;113-117.
25. Watt N.T., Hooper N.M. The response of neurones and glial cells to elevated copper. Brain Res. Bull. 55(2):2001;219-224.
26. 2+. Toxicology. 143(3):2000;263-273.
27. Luza S.C., Speisky H.C. Liver copper storage and transport during development: implications for cytotoxicity. Am. J. Clin. Nutr. 63(5):1996;812S-820S.
28. + with mitochondria. Acta Chem. Scand. 45(10):1991;1042-1046.
29. Zamzami N., Marchetti P., Castedo M., Zanin C., Vayssiere J.L., Petit P.X., Kroemer G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181(5):1995;1661-1672.
30. Kunitake S.T., Jarvis M.R., Hamilton R.L., Kane J.P. Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 89(15):1992;6993-6997.
31. Mackness M.I., Durrington P.N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis. 115(2):1995;243-253.
32. Bowry V.W., Stanley K.K., Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl. Acad. Sci. 89(21):1992;10316-10320.
33. Suc I., Escargueil-Blanc I., Troly M., Salvayre R., Negre-Salvayre A. HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 17:1997;2158-2166.
34. Nofer J.R., Kehrel B., Fobker M., Levkau B., Assmann G., von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 161(1):2002;1-16.
35. Park S.H., Park J.H., Kang J.S., Kang Y.H. Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression. Int. J. Biochem. Cell Biol. 35(2):2003;168-182.
36. Bassett C.N., Neely M.D., Sidell K.R., Markesbery W.R., Swift L.L., Montine T.J. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo. Lipids. 34(12):1999;1273-1280.
37. Rodrigo L., Hernandez A.F., Lopez-Caballero J.J., Gil F., Pla A.R. Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem. Biol. Interact. 137(2):2001;123-137.